Personal information

Other IDs

SciProfiles: 1433173

Activities

Collapse all

Works (18)

Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification

Nature Reviews Urology
2025-02 | Journal article
DOI: 10.1038/s41585-024-00914-7
Contributors: Mitchell Olislagers; Florus C. de Jong; Vera C. Rutten; Joost L. Boormans; Tokameh Mahmoudi; Tahlita C. M. Zuiverloon
Source: check_circle
Crossref

PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG

World Journal of Urology
2025-01-03 | Journal article
DOI: 10.1007/s00345-024-05392-5
Contributors: Florus C. de Jong; Vebjørn Kvikstad; Robert F. Hoedemaeker; Angelique C. J. van der Made; Thierry P. van der Bosch; Niels J. van Casteren; Kim E. M. van Kessel; Ellen C. Zwarthoff; Joost L. Boormans; Tahlita C. M. Zuiverloon
Source: check_circle
Crossref

Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research
2024-12-02 | Journal article
DOI: 10.1158/1078-0432.CCR-24-2015
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Data from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.c.7565473
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Figure S1 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938278
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Figure S2 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938275
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Figure S3 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938272
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Figure S4 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938266
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Figure S5 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938263
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Figure S6 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938260
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Supplementary Data Tables 1 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938257
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Supplementary Methods 1 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938254
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Supplementary Table Legend 1 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938251
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Supplementary Table Names 1 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

2024-12-02 | Preprint
DOI: 10.1158/1078-0432.27938248
Contributors: Joel R. Eisner; Florus C. de Jong; Yoichiro Shibata; Gregory M. Mayhew; James M. Davison; Jenna Carcione; Kirk L. Pappan; Shibu Thomas; Spyros Triantos; Ademi Santiago-Walker et al.
Source: check_circle
Crossref

Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin

Science Translational Medicine
2023-05-24 | Journal article
DOI: 10.1126/scitranslmed.abn4118
Contributors: Florus C. de Jong; Teemu D. Laajala; Robert F. Hoedemaeker; Kimberley R. Jordan; Angelique C. J. van der Made; Egbert R. Boevé; Deric K. E. van der Schoot; Bart Nieuwkamer; Emiel A. M. Janssen; Tokameh Mahmoudi et al.
Source: check_circle
Crossref

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes

International Journal of Molecular Sciences
2022-09-14 | Journal article
DOI: 10.3390/ijms231810605
Contributors: Sébastien Rinaldetti; Qiong Zhou; Joshua M. Abbott; Florus C. de Jong; Hector Esquer; James C. Costello; Dan Theodorescu; Daniel V. LaBarbera
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical Bacillus Calmette-Guérin

2021-12-05 | Preprint
DOI: 10.1101/2021.11.30.21266988
Contributors: Florus C. de Jong; Teemu D. Laajala; Robert F. Hoedemaeker; Kimberley R. Jordan; Angelique C.J. van der Made; Egbert R. Boevé; Deric K.E. van der Schoot; Bart Nieuwkamer; Emiel A.M. Janssen; Tokameh Mahmoudi et al.
Source: check_circle
Crossref

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer

International Journal of Molecular Sciences
2021-03-10 | Journal article
DOI: 10.3390/ijms22062800
Contributors: Florus C. de Jong; Vera C. Rutten; Tahlita C. M. Zuiverloon; Dan Theodorescu
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Peer review (1 review for 1 publication/grant)

Review activity for Urologic oncology. (1)
How many people are using ORCID?